Insider Trading Activity For Arbutus Biopharma Corporation (NASDAQ:ABUS)
Michael J Sofia , Insider of Arbutus Biopharma Corporation (NASDAQ:ABUS) reportedly Sold 30,000 shares of the company’s stock at an average price of 3.7 for a total transaction amount of $111,000.00 SEC Form
Insider Trading History For Arbutus Biopharma Corporation (NASDAQ:ABUS)
Analyst Ratings For Arbutus Biopharma Corporation (NASDAQ:ABUS)
These are 1 Hold Rating, 6 Buy Ratings .
The current consensus rating for Arbutus Biopharma Corporation (NASDAQ:ABUS) is Buy (Score: 2.86) with a consensus target price of $13.75 , a potential (281.94% upside)
Analyst Ratings History For Arbutus Biopharma Corporation (NASDAQ:ABUS)
- with a price target of $20.00 to $12.00
- On 8/17/2016 Leerink Swann Downgraded rating Outperform to Market Perform
- On 8/21/2016 William Blair Reiterated Rating Outperform
- On 11/6/2016 JMP Securities Reiterated Rating Buy
- On 1/9/2017 Bloom Burton Upgraded rating Accumulate to Buy
- On 3/22/2017 Wedbush Reiterated Rating Outperform with a price target of $9.00 to $10.00
- On 6/2/2017 Ladenburg Thalmann Financial Services Initiated Coverage of rating Buy with a price target of $32.00
Recent Trading Activity for Arbutus Biopharma Corporation (NASDAQ:ABUS)
Shares of Arbutus Biopharma Corporation closed the previous trading session at 3.60 down -0.10 -2.70% with 28,173 shares trading hands.